SCA
AGN

Signpost Capital Advisors’s Allergan plc AGN Stock Holding History

Signpost Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-49,500
Closed -$13.3M – 19
2016
Q1 		$13.3M Buy
49,500
+6,500
+15% +$1.86M 6.21% 7
2015
Q4 		$13.4M Buy
+43,000
New +$12.8M 3.6% 9

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Signpost Capital Advisors's AGN Position: Q1 2016 in Review

Signpost Capital Advisors sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 65,409 shares — an estimated $18.7M sold.

Signpost Capital Advisors first reported a position in AGN in Q3 2015 and held it in 2 quarters. The position peaked at $20.4M in Q4 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Signpost Capital Advisors reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Signpost Capital Advisors sold 65,409 Allergan plc shares in Q1 2016, an estimated $18.7M.
  • Signpost Capital Advisors first reported a position in Allergan plc in Q3 2015 and held it in 2 quarters.
  • Signpost Capital Advisors's Allergan plc position peaked at $20.4M in Q4 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Signpost Capital Advisors's 13F filing for Q1 2016, filed 13 May 2016.